Dudediligence.

Kymera Therapeutics, Inc

KYMRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 510-QQuarterly report
  2. Aug 58-KResults of operations2.029.01
  3. Jul 278-KOfficer or director change and Regulation FD disclosure5.027.019.01
  4. Jun 258-KRegulation FD disclosure and other events7.018.019.01
  5. Jun 248-KShareholder vote5.07
  6. Jun 88-KOfficer or director change5.02
  7. Apr 3010-QQuarterly report
  8. Apr 308-KResults of operations2.029.01
  9. Mar 278-KBylaws or fiscal year changed5.039.01
  10. Feb 268-KMaterial agreement and other events1.011.028.019.01
  11. Feb 26424B3Prospectus for an offering
  12. Feb 26424B5Prospectus for an offering
  13. Feb 2610-KAnnual report
  14. Feb 268-KResults of operations2.029.01
  15. Jan 138-KResults of operations and Regulation FD disclosure2.027.019.01
  16. Dec 10, 20258-KMaterial agreement and other events1.018.019.01
  17. Dec 10, 2025424B5Prospectus for an offering
  18. Dec 8, 2025424B5Prospectus for an offering
  19. Dec 8, 20258-KRegulation FD disclosure7.019.01
  20. Dec 8, 20258-KRegulation FD disclosure and other events7.018.019.01
  21. Nov 4, 202510-QQuarterly report